Updated Date:
20 Jul 2026
Product Detail:
SALBUTAMOL CIPLA salbutamol 2.5mg/2.5mL (as sulfate) inhalation ampoules
Shortage Status:
Discontinued
AUST R:
115652
Availability:
Unavailable
Active Ingredient:
salbutamol sulfate
Reason:
Manufacturing
Dosage Form:
Inhalation,conventional
Supply Impact Dates
Management Action:
An overseas-registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals